9 Patents
- US124213172025Polynucleotides Encoding Anti-glucagon-like Peptide 1 Receptor (GLP1R) Antagonist Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites - US122801242025Antibody-drug Conjugates Comprising GLP1 Peptidomimetics and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122698892025Human Antibodies to the Human Glucagon Receptor (HGCGR) and Methods of Use Thereof to Lower Blood Glucose or Ketone Levels
REGENERON PHARMACEUTICALS, Inc.
0 cites - US121395462024Methods of Treating Urea Cycle Disorders by Interfering with Glucagon Receptor Signaling
REGENERON PHARMACEUTICALS, Inc.
0 cites - US120901932024Glucagon-like Peptide 1 Receptor Agonists and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US118847362024Antibodies Which Bind to Glucagon-like Peptide 1 Receptor (GLP1R)
Regeneron Pharmaceuticals, Inc.
0 cites - US117796332023Glucagon-like Peptide 1 Receptor Agonists and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US117084162023Methods of Treating Severe Insulin Resistance by Interfering with Glucagon Receptor Signaling
REGENERON PHARMACEUTICALS, Inc.
0 cites